Efficacy News and Research

RSS
Advanced Life Sciences participates as exhibitor in 50th ICAAC

Advanced Life Sciences participates as exhibitor in 50th ICAAC

New clinical trial supports benefits of turmeric extract to people with osteoarthritis

New clinical trial supports benefits of turmeric extract to people with osteoarthritis

Daily doses of ginger relieve muscle pain: Research

Daily doses of ginger relieve muscle pain: Research

BioCryst reports results from forodesine studies for CTCL and CLL

BioCryst reports results from forodesine studies for CTCL and CLL

AVANIR's AVP-923 Phase III STAR trial results published in 'Annals of Neurology' website

AVANIR's AVP-923 Phase III STAR trial results published in 'Annals of Neurology' website

Bone marrow-derived mononuclear cell therapy benefits patients after severe heart attack

Bone marrow-derived mononuclear cell therapy benefits patients after severe heart attack

Neurocrine Biosciences announces GSK561679 antagonist's efficacy in major depressive disorder

Neurocrine Biosciences announces GSK561679 antagonist's efficacy in major depressive disorder

RAB-1 monoclonal antibody study shows positive result for rabies

RAB-1 monoclonal antibody study shows positive result for rabies

20-20 Gene Systems launches L-IHC staining for biomarker identification in tumors

20-20 Gene Systems launches L-IHC staining for biomarker identification in tumors

PLX-PAD therapy improves quality of life in CLI patients

PLX-PAD therapy improves quality of life in CLI patients

microRNA 451 enhances treatment response in stomach cancer patients: Research

microRNA 451 enhances treatment response in stomach cancer patients: Research

Provectus completes enrollment in first cohort of PV-10 Phase 1 trial for liver cancer

Provectus completes enrollment in first cohort of PV-10 Phase 1 trial for liver cancer

CytoGenix reports positive results of CYDBA507 avian influenza vaccine candidate

CytoGenix reports positive results of CYDBA507 avian influenza vaccine candidate

ThermoGenesis 2010 fourth quarter revenue increases to $7.2 million

ThermoGenesis 2010 fourth quarter revenue increases to $7.2 million

Data from Phase II trial of zanolimumab in PTCL published in British Journal of Haematology

Data from Phase II trial of zanolimumab in PTCL published in British Journal of Haematology

Enrollment in Derma Sciences DSC127 Phase 2 trial in diabetic foot ulcer healing to conclude September end

Enrollment in Derma Sciences DSC127 Phase 2 trial in diabetic foot ulcer healing to conclude September end

AstraZeneca Chief Scientist shares enthusiasm for collaborative clinical research

AstraZeneca Chief Scientist shares enthusiasm for collaborative clinical research

AMCP supports legislation to prohibit financial agreements for delaying marketing of lower-cost generic drugs

AMCP supports legislation to prohibit financial agreements for delaying marketing of lower-cost generic drugs

Gilead Sciences announces Quad regimen Phase II clinical trial results for HIV infection treatment

Gilead Sciences announces Quad regimen Phase II clinical trial results for HIV infection treatment

Progenics Pharmaceuticals presents findings of humanized monoclonal antibodies against C. difficile bacterium

Progenics Pharmaceuticals presents findings of humanized monoclonal antibodies against C. difficile bacterium

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.